1)Bajgai P, Katoch D, Dogra MR et al:Idiopathic retinal vasculitis, aneurysms, and neuroretinitis(IRVAN)syndrome:clinical perspectives. Clin Ophthalmol 11:1805-1817, 2017
2)Massicotte E, Hassanaly S, Bélair ML et al:Long-term outcomes in a series of idiopathic retinal vasculitis, aneurysms, and neuroretinitis(IRVAN)syndrome. Can J Ophthalmol 53:435-440, 2018
3)Singh R, Sharma K, Agarwal A et al:Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient with idiopathic retinal vasculitis, aneurysms and neuroretinitis. J Ophthalmic Inflamm Infect 6:8, 2016
4)El-Asrar AMA, Jestaneiah S, Al-Serhani AM:Regression of aneurysmal dilatations in a case of idiopathic retinal vasculitis, aneurysms and neuroretinitis(IRVAN)associated with allergic fungal sinusitis. Eye(Lond)18:197-199, 2004
5)Samuel MA, Equi RA, Chang TS et al:Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis(IRVAN):new observations and a proposed staging system. Ophthalmology 114:1526-1529, 2007
6)Rouvas A, Nikita E, Markomichelakis N et al:Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis:clinical course and treatment. J Ophthalmic Inflamm Infect 3:21, 2013
7)Moosavi M, Hosseini SM, Shoeibi N et al:Unilateral idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome(IRVAN)in a young female. J Curr Ophthalmol 27:63-66, 2015
8)Cheema RA, Al-Askar E, Cheema HR:Infliximab therapy for idiopathic retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther 27:407-410, 2011
9)Akesbi J, Brousseaud FX, Adam R et al:Intravitreal bevacizumab(Avastin)in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis. Acta Ophthalmol 88:e40-e41, 2010